Emerging resistance pathways in lung cancer: what has ROS-1 taught us?

Transl Lung Cancer Res. 2018 Feb;7(Suppl 1):S9-S12. doi: 10.21037/tlcr.2017.11.13.

Authors

Doraid Alrifai¹, Martin D Forster², Sam M Janes¹

Affiliations

¹ Lungs for Living Research Centre, UCL Respiratory, Rayne Institute, University College London, London, UK.
² UCL Cancer Institute, University College London, London, UK.

No abstract available

Publication types

Editorial
Comment

Grants and funding